A novel accurate amplification created restriction site method for determination of the wild type and the precore mutant hepatitis B virus variants

被引:8
作者
Amini-Bavil-Olyaee, S
Sarrami-Forooshani, R
Adeli, A
Mahboudi, F
Sabahi, F
Nafisi, H
Zali, MR
Azizi, M
机构
[1] Pasteur Inst Iran, Dept Biotechnol, Tehran 13164, Iran
[2] Tarbiat Modares Univ, Fac Med Sci, Dept Virol, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Res Ctr Gastroenterol & Liver Dis, Tehran, Iran
关键词
hepatitis B virus; precore mutant; ACRS method; Iranian patients;
D O I
10.1016/j.jviromet.2005.02.011
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The most commonly occurring hepatitis B virus (HBV) mutation is the G to A mutation at nucleotide 1896 in the precore region. The aim of this study was to develop a novel accurate amplification created restriction site (ACRS) method for determination of the TGG wild type and the TAG precore mutant HBV variants. Two conserved and consensus specific and diagnostic primers introducing BstXI and XagI cleavage sites were designed in order to determine the G1896 wild type and the A1896 precore mutant HBV variants in all HBV genotypes. The results of the ACRS method were compared with sequencing data. With the ACRS method, three different patterns could be distinguished for the wild type, the precore mutant and mixed infection HBV variants. The results of the ACRS method on 30 HBV isolates revealed the TAG precore mutant in 50% (15/30), the TGG wild type variant in 30% (9/30) and the mixed infection in 20% (6/30). The sequencing data of these samples were in agreement with the ACRS results. The ACRS method is a rapid and cost-effective technique for detecting both the TGG wild type and the TAG HBV precore mutant variants. It can be carried out for follow-up of G1896A precore mutant variant in hepatitis B virus infected subjects at routine molecular diagnostic laboratories. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:19 / 23
页数:5
相关论文
共 33 条
[1]
Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients [J].
Amini-Bavil-Olyaee, S ;
Sarrami-Forooshani, R ;
Mahboudi, F ;
Sabahi, F ;
Adeli, A ;
Noorinayer, B ;
Azizi, M ;
Zali, MR .
JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (02) :227-234
[2]
Colourimetric point mutation assay: For detection of precore mutants of hepatitis B [J].
Ballard, AL ;
Boxall, EH .
JOURNAL OF VIROLOGICAL METHODS, 1997, 67 (02) :143-152
[3]
CHRONIC HEPATITIS IN HBSAG-CARRIERS WITH SERUM HBV-DNA AND ANTI-HBE [J].
BONINO, F ;
ROSINA, F ;
RIZZETTO, M ;
RIZZI, R ;
CHIABERGE, E ;
TARDANICO, R ;
CALLEA, F ;
VERME, G .
GASTROENTEROLOGY, 1986, 90 (05) :1268-1273
[4]
HEPATITIS-B VIRUS UNABLE TO SECRETE E-ANTIGEN AND RESPONSE TO INTERFERON IN CHRONIC HEPATITIS-B [J].
BRUNETTO, MR ;
GIARIN, M ;
SARACCO, G ;
OLIVERI, F ;
CALVO, P ;
CAPRA, G ;
RANDONE, A ;
ABATE, ML ;
MANZINI, P ;
CAPALBO, M ;
PIANTINO, P ;
VERME, G ;
BONINO, F .
GASTROENTEROLOGY, 1993, 105 (03) :845-850
[5]
CARMAN WF, 1989, LANCET, V2, P588
[6]
Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic [J].
Chu, CM ;
Yeh, CT ;
Chiu, CT ;
Sheen, IS ;
Liaw, YF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (07) :1815-1818
[7]
Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: Clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion [J].
Chu, CM ;
Yeh, CT ;
Lee, CS ;
Sheen, IS ;
Liaw, YF .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (01) :16-21
[8]
HADZIYANNIS SJ, 1983, HEPATOLOGY, V3, P656
[9]
Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
[10]
PRECORE MUTANT OF HEPATITIS-B VIRUS IN CHILDHOOD FULMINANT-HEPATITIS-B - AN INFREQUENT ASSOCIATION [J].
HSU, HY ;
CHANG, MH ;
LEE, CY ;
HSIEH, KH ;
NI, YH ;
CHEN, PJ ;
CHEN, DS .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :776-781